Gideon Dreyfuss

Results: 4



#Item
1Fall 2012 BGS Newsletter BGS CONVOCATION Welcome to BGS The new academic year is starting, and the Penn campus is abuzz with

Fall 2012 BGS Newsletter BGS CONVOCATION Welcome to BGS The new academic year is starting, and the Penn campus is abuzz with

Add to Reading List

Source URL: www.med.upenn.edu

Language: English - Date: 2012-08-31 14:20:01
2Spinal Muscular Atrophy & ISIS-SMNRx Isis Pharmaceuticals is developing a drug to treat Spinal Muscular Atrophy (SMA). SMA is a genetic neuromuscular disease characterized by muscle atrophy and weakness. SMA is a leading

Spinal Muscular Atrophy & ISIS-SMNRx Isis Pharmaceuticals is developing a drug to treat Spinal Muscular Atrophy (SMA). SMA is a genetic neuromuscular disease characterized by muscle atrophy and weakness. SMA is a leading

Add to Reading List

Source URL: www.muscle.ca

Language: English - Date: 2013-11-30 18:15:27
3G R A D UAT E S T U D I E S I N  Biochemistry and Molecular Biophysics  Overview

G R A D UAT E S T U D I E S I N Biochemistry and Molecular Biophysics Overview

Add to Reading List

Source URL: www.med.upenn.edu

Language: English - Date: 2011-11-11 08:10:10
4Draft Meeting Program: Subject to Change Thursday June 13 Special Session: Enhancing the Predictive Ability of Preclinical Drug Studies, Session Moderator, Charlotte Sumner, MD The goal of this session is to discuss the

Draft Meeting Program: Subject to Change Thursday June 13 Special Session: Enhancing the Predictive Ability of Preclinical Drug Studies, Session Moderator, Charlotte Sumner, MD The goal of this session is to discuss the

Add to Reading List

Source URL: www.fsma.org

Language: English - Date: 2013-04-29 14:04:28